Jain Foundation Inc Email Format

Research ServicesWashington, United States11-50 Employees

Jain Foundation Inc is a Seattle-based research organization focused on developing a cure for muscular dystrophies caused by dysferlin protein deficiency, conditions collectively known as dysferlinopathy and clinically referred to as LGMD2B, LGMDR2, or Miyoshi Myopathy 1. The foundation operates a non-traditional funding model that supports and partners with scientific researchers, institutions, and companies, while also providing logistical help in drug development and clinical trials and maintaining a patient support and advocacy platform. Its services are directed at researchers, clinical developers, and patient communities seeking to advance therapies for dysferlinopathy, addressing gaps in research funding, coordination, and trial execution. Based in the city and region of Seattle, the organization maintains an emphasis on collaboration, preclinical research, and translational activities within the broader research services industry. A notable recent development is the launch of the R1925X mouse model to aid researchers studying this disease area. The foundation operates within a landscape that includes other patient-focused and research-oriented organizations pursuing muscular dystrophy and rare disease research.

Sign up for free to view info

Company overview Employee directory